ArticleHeliyon2024
A comprehensive learning based swarm optimization approach for feature selection in gene expression data.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Open challenges and opportunities in federated foundation models towards biomedical healthcare.BioData mining · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gene expression data analysis is challenging due to the high dimensionality and complexity of the data. Feature selection, which identifies relevant genes, is a common preprocessing step. We propose a Comprehensive Learning-Based Swarm Optimization (CLBSO) approach for feature selection in gene expression data. CLBSO leverages the strengths of ants and grasshoppers to efficiently explore the high-dimensional search space. Ants perform local search and leave pheromone trails to guide the swarm, while grasshoppers use their ability to jump long distances to explore new regions and avoid local optima. The proposed approach was evaluated on several publicly available gene expression datasets and compared with state-of-the-art feature selection methods. CLBSO achieved an average accuracy improvement of 15% over the original high-dimensional data and outperformed other feature selection methods by up to 10%. For instance, in the Pancreatic cancer dataset, CLBSO achieved 97.2% accuracy, significantly higher than XGBoost-MOGA's 84.0%. Convergence analysis showed CLBSO required fewer iterations to reach optimal solutions. Statistical analysis confirmed significant performance improvements, and stability analysis demonstrated consistent gene subset selection across different runs. These findings highlight the robustness and efficacy of CLBSO in handling complex gene expression datasets, making it a valuable tool for enhancing classification tasks in bioinformatics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.